Investing.com -- Moody’s Ratings has upgraded Intrum AB’s corporate family rating to Caa2 from Ca following the completion of the company’s court-supervised debt restructuring process.

Investing.com -- Moody’s Ratings has affirmed Ayvens’ long-term issuer and senior unsecured debt ratings at A1 and changed the outlook to stable from negative, the rating agency announced Friday. The ...

Investing.com -- Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has formed a strategic partnership with Tether to accelerate cryptocurrency adoption across Brazil through ...

S&P Global Ratings has downgraded Singapore Post Ltd. to ’BBB-’ from ’BBB’ with a stable outlook following the company’s significant operational scale-down. The rating action comes after SingPost ...

Davis Commodities Ltd (NASDAQ:DTCK) stock gained 6.3% after the Singapore-based agricultural trading firm announced it is conducting a strategic review of a Fractal Bitcoin Reserve model and tokenized ...

Investing.com -- Jefferies upgraded Union Pacific (NYSE: UNP) and downgraded Norfolk Southern (NYSE: NSC) saying the former ...

Investing.com -- Goldman Sachs said in a note Friday that its Speculative Trading Indicator has surged to historic levels, reaching its highest reading outside of the dot-com and pandemic-era bubbles.

Following the launch of the all-electric EX90 seven-seater, Volvo Car South Africa (VCSA) is reiterating its commitment to ...

(Reuters) -Tesla is preparing to launch its robotaxi service in San Francisco as soon as this weekend, Business Insider ...

Investing.com -- Palantir Technologies is a high-risk but potentially transformative investment, according to Piper Sandler, ...

Investing.com -- Goldman Sachs has initiated coverage on Gubra A/S with a “neutral” rating and a 12-month price target of Dkr520, representing a 23.9% upside from the current price of Dkr419.80, in a ...

The clinical-stage biopharmaceutical company revealed that NC605 demonstrated improved bone microarchitecture and reduced fracture incidence compared to anti-sclerostin treatment in a well-established ...